11. SEGMENTS (Tables)

6 Months Ended

Jun. 30, 2018

Segment Reporting [Abstract]

Summarized segment financial information

Three Months Ended June 30, 2018
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	2,144,724		$	2,476,117		$	35,709		$	4,656,550
Cost of product revenue		7,965,681			1,679,981			—			9,645,662
Loss from operations		(9,918,243	)		(941,993	)		(2,557,145	)		(13,417,381	)
Interest and other expense, net		(237,161	)		(436	)		(1,092,853	)		(1,330,450	)
Net loss		(10,155,404	)		(942,429	)		(3,649,998	)		(14,747,831	)
Total assets		54,297,915			5,438,645			58,015,432			117,751,992
Depreciation and amortization expense		639,300			200,598			6,001			845,899

Six Months Ended June 30, 2018
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	3,810,967		$	4,816,172		$	71,417		$	8,698,556
Cost of product revenue		18,663,323			3,225,087			—			21,888,410
Loss from operations		(22,642,709	)		(1,980,817	)		(5,326,358	)		(29,949,884	)
Interest and other expense, net		(477,214	)		(871	)		(2,142,004	)		(2,620,089	)
Net loss		(23,119,923	)		(1,981,688	)		(7,468,362	)		(32,569,973	)
Capital expenditures		591,665			454,710			—			1,046,375
Depreciation and amortization expense		1,271,131			389,512			14,796			1,675,439

Three Months Ended June 30, 2017
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	539,223		$	2,824,469		$	35,709		$	3,399,401
Cost of product revenue		2,498,856			1,835,163			—			4,334,019
Loss from operations		(3,118,300	)		(610,864	)		(4,672,704	)		(8,401,868	)
Interest and other expense, net		(61,987	)		—			(572,640	)		(634,627	)
Net loss		(3,180,287	)		(610,864	)		(5,245,344	)		(9,036,495	)
Total assets		65,913,839			2,101,977			16,623,437			84,639,253
Depreciation and amortization expense		158,398			103,703			15,031			277,132

Six Months Ended June 30, 2017
	ADMA BioManufacturing			Plasma Collection Centers			Corporate			Consolidated
Revenues	$	539,223		$	5,417,632		$	71,417		$	6,028,272
Cost of product revenue		2,498,856			3,451,450			—			5,950,306
Loss from operations		(3,118,300	)		(1,113,464	)		(10,107,107	)		(14,338,871	)
Interest and other expense, net		(61,987	)		—			(1,172,600	)		(1,234,587	)
Net loss		(3,180,287	)		(1,113,464	)		(11,279,707	)		(15,573,458	)
Depreciation and amortization expense		158,398			207,343			29,453			395,194
Capital expenditures		—			81,294			15,263			96,557